Effect of magnesium supplementation in treatment of diabetic hemodialysis patients
Phase 3
- Conditions
- Hemodialysis.Chronic kidney disease
- Registration Number
- IRCT2017090133941N19
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diabetic hemodialysis patients
Aged 18 to 80 years
Exclusion Criteria
Patients with inflammatory and malignant diseases
Taking magnesium supplements, antioxidant and/or anti-inflammatory supplements within 3 months prior to enrollment in the study
Taking immunosuppressive agents
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum right CIMT. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Sonography.;Mean left CIMT. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Sonography.;Maximum left CIMT. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Sonography.;Mean right CIMT. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method